
The scale of zombie funds threatens to lock up capital, altering return expectations and pressuring firms to innovate, while secondary market constraints could slow liquidity solutions for investors.
The rise of so‑called zombie funds—private‑equity vehicles that linger beyond their investment horizon without meaningful exits—has moved from a niche concern to a mainstream risk. Analysts estimate that by the end of the decade these funds could command about $1 trillion in net asset value, a figure driven by prolonged holding periods, limited IPO windows, and a slowdown in strategic sales. This capital lock‑up not only depresses internal rates of return but also reduces the pool of deployable capital for new deals, reshaping fundraising dynamics across the industry.
In response, general partners are rethinking traditional playbooks. Firms are emphasizing operational value creation, extending partnership terms, and exploring hybrid structures that blend primary commitments with secondary liquidity options. The "new era" of private equity demands greater transparency, more frequent reporting, and flexible redemption mechanisms to retain limited partners’ confidence. Moreover, managers are leveraging technology and data analytics to identify opportunistic exits, even in constrained markets, thereby mitigating the drag of dormant assets.
Despite these strategic shifts, the secondary market—a key outlet for unlocking value in zombie funds—faces inherent limits. Liquidity constraints, valuation disagreements, and heightened regulatory scrutiny slow transaction velocity. Buyers remain cautious, demanding deeper due diligence and price discounts, which can cap the volume of secondary deals. Consequently, while the secondary market will continue to provide a vital escape hatch, its growth is likely to be incremental rather than explosive, underscoring the need for primary managers to proactively manage portfolio lifecycles.
Comments
Want to join the conversation?
Loading comments...